Morgan Stanley Starts Illumina (ILMN) at Equalweight
More News related to ILMN
- Unusual 11 Mid-Day Movers 7/2: NAVI, AVNR, ESLR, ELN Higher; DSCO, SEPR, TIVO, ILMN Lower
- Morning Movers 7/2: ELN, QUIK, ESLR Higher; DSCO, LEA, SEPR, ILMN, MANH Lower
- Illumina (ILMN) volatility low into preannounced lower Q2 revenue
- Illumina (ILMN): Defended following a negative pre-announcement
- Illumina Launches Multi-Sample Indexing for GoldenGate(R) Assay
Morgan Stanley initiates coverage on Illumina (Nasdaq: ILMN) with an Equalweight rating.
Illumina, Inc. engages in the development, manufacture, and marketing of integrated systems for the analysis of genetic variation and biological function.
Related Categories
New CoverageStocks Mentioned
-4.68Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
